{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:40:57Z","timestamp":1782423657091,"version":"3.54.5"},"reference-count":32,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Moscow Health Care Department","award":["123031400008-4"],"award-info":[{"award-number":["123031400008-4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Inflammatory bowel diseases (IBD), associated with a significant burden on patients\u2019 lives, are becoming increasingly common. Patients with IBD need continuous treatment and lifelong monitoring, which could be achieved by telemonitoring. Telemonitoring has been shown to be effective in improving outcomes for patients with IBD, and can provide a more convenient and accessible way for patients to receive care. However, the certainty of evidence remains low. This article outlines the methodology of a randomized control study that aims to assess the efficacy of telemonitoring compared to face-to-face follow-up for patients with IBD in Russia, hypothesizing that the implementation of telemonitoring will lead to improvement in clinical, social, and organizational areas. Methods: The TIGE-Rus study is a randomized controlled trial. The study consists of three stages, including selection of patients and random assignment into two groups with a ratio of 1:1, follow-up care using telemonitoring or face-to-face appointments, and evaluation and comparison of follow-up efficacy in both groups. In the first stage, all patients will undergo laboratory tests and instrumental examinations, and fill out questionnaires to measure disease activity, quality of life, medication adherence, psychological well-being, and satisfaction with medical care. In the second stage, the control group will receive standard care while the telemonitoring group will have access to a web platform where they can report their clinical activity, fill out questionnaires, and have online consultations with gastroenterologists. The gastroenterologists will also make monthly phone calls to each patient in the telemonitoring group to monitor their progress. In the third stage of the study, both the telemonitoring group and the control group will be re-hospitalized after six months of monitoring. IBD activity will be evaluated through laboratory and instrumental examinations. Additionally, all the participants will complete questionnaires to assess the disease activity, medication adherence, quality of life, psychological well-being, and satisfaction with medical care in both groups. Conclusions: The trial will explore whether telemonitoring is effective in improving clinical, social, and organizational aspects in the management of patients with IBD in the setting of the Russian healthcare system.<\/jats:p>","DOI":"10.3390\/jcm13247734","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T09:43:03Z","timestamp":1734514983000},"page":"7734","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of Telemedicine in Inflammatory Bowel Disease in Russia: TIGE-Rus (Telemonitoring for IBD Goodness Examination in Russia) Study Protocol of a Randomized Controlled Trial"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7705-9754","authenticated-orcid":false,"given":"Dina A.","family":"Akhmedzyanova","sequence":"first","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8521-4045","authenticated-orcid":false,"given":"Yuliya F.","family":"Shumskaya","sequence":"additional","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy A.","family":"Vasilev","sequence":"additional","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton V.","family":"Vladzymyrskyy","sequence":"additional","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-4431","authenticated-orcid":false,"given":"Olga V.","family":"Omelyanskaya","sequence":"additional","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulya A.","family":"Alymova","sequence":"additional","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina G.","family":"Mnatsakanyan","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr S.","family":"Panferov","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Taschyan","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Kuprina","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta V.","family":"Yurazh","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur S.","family":"Eloev","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, The First Sechenov Moscow State Medical University (Sechenov University), Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman V.","family":"Reshetnikov","sequence":"additional","affiliation":[{"name":"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow 127051, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The Burden of Inflammatory Bowel Disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","article-title":"Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data","volume":"156","author":"Coward","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ibd\/izab074","article-title":"Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996\u20132016","volume":"28","author":"Singh","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.crohns.2014.03.005","article-title":"IBD and Health-Related Quality of Life\u2014Discovering the True Impact","volume":"8","author":"Vermeire","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target Strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5662\/wjm.v13.i4.194","article-title":"Telemedicine in Inflammatory Bowel Diseases: A New Brick in the Medicine of the Future?","volume":"13","author":"Gravina","year":"2023","journal-title":"World J. Methodol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3748\/wjg.v30.i1.17","article-title":"May ChatGPT Be a Tool Producing Medical Information for Common Inflammatory Bowel Disease Patients\u2019 Questions? An Evidence-Controlled Analysis","volume":"30","author":"Gravina","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ibd\/izac115","article-title":"A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation","volume":"28","author":"Stafford","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/00365521.2018.1451915","article-title":"Adherence, Risk Factors of Non-Adherence and Patient\u2019s Preferred Treatment Strategy of Mesalazine in Ulcerative Colitis: Multicentric Observational Study","volume":"53","author":"Keil","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s10620-021-07025-y","article-title":"Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review","volume":"67","author":"Balram","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e28978","DOI":"10.2196\/28978","article-title":"Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"24","author":"Pang","year":"2022","journal-title":"J. Med. Internet Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41395-018-0272-8","article-title":"A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)","volume":"114","author":"Cross","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.17816\/DD545997","article-title":"Delphi Method to Determine a List of Questionnaire-Assessed Parameters in the Follow-up of Patients with Inflammatory Bowel Disease","volume":"4","author":"Shumskaya","year":"2023","journal-title":"Digit. Diagn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 Explanation and Elaboration: Guidance for Protocols of Clinical Trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A Simple Clinical Colitis Activity Index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A Simple Index of Crohn\u2019s-Disease Activity","volume":"315","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"ref_17","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: A Quality of Life Instrument for Community Physicians Managing Inflammatory Bowel Disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"The Whoqol Group (1998). Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol. Med., 28, 551\u2013558.","DOI":"10.1017\/S0033291798006667"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/03007995.2023.2196219","article-title":"Exploration of the Psychometric Properties of the Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients","volume":"39","author":"Meng","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21747","DOI":"10.3402\/meo.v18i0.21747","article-title":"The Patient Satisfaction Questionnaire Short Form (PSQ-18) as an Adaptable, Reliable, and Validated Tool for Use in Various Settings","volume":"18","author":"Thayaparan","year":"2013","journal-title":"Med. Educ. Online"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1037\/pas0001181","article-title":"Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis","volume":"35","author":"Wu","year":"2023","journal-title":"Psychol. Assess."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e14384","DOI":"10.1111\/nmo.14384","article-title":"The Visceral Sensitivity Index: A Novel Tool for Measuring GI-symptom-specific Anxiety in Inflammatory Bowel Disease","volume":"34","author":"Trieschmann","year":"2022","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000287950","article-title":"Toronto Alexithymia Scale: Relationship with Personality and Psychopathology Measures","volume":"45","author":"Bagby","year":"1986","journal-title":"Psychother. Psychosom."},{"key":"ref_24","first-page":"10","article-title":"Ulcerative Colitis (K51), Adults","volume":"22","author":"Shelygin","year":"2023","journal-title":"Koloproktologia"},{"key":"ref_25","first-page":"10","article-title":"Clinical Guidelines: Crohn\u2019s Disease (\u041a50), Adults","volume":"22","author":"Shelygin","year":"2023","journal-title":"Koloproktologia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jsps.2020.07.005","article-title":"Translation and Validation of the Arabic Version of the General Medication Adherence Scale (GMAS) in Saudi Patients with Chronic Illnesses","volume":"28","author":"Naqvi","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12955-021-01890-x","article-title":"Psychometric Validation of the Chinese Version of the Short Inflammatory Bowel Disease Questionnaire and Evaluation of Its Measurement Invariance across Sex","volume":"19","author":"Sun","year":"2021","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/j.1572-0241.2001.04682.x","article-title":"The Short Inflammatory Bowel Disease Questionnaire Is Reliable and Responsive to Clinically Important Change in Ulcerative Colitis","volume":"96","author":"Jowett","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-Analyses\u2014Part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9270(01)04037-0","article-title":"Quality of Life in Inflammatory Bowel Disease in Remission: The Impact of IBS-like Symptoms and Associated Psychological Factors","volume":"97","author":"Simren","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_31","first-page":"78","article-title":"Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic Review","volume":"117","author":"Nguyen","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12961-019-0494-2","article-title":"Intervention Scalability Assessment Tool: A Decision Support Tool for Health Policy Makers and Implementers","volume":"18","author":"Milat","year":"2020","journal-title":"Health Res. Policy Syst."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7734\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:50Z","timestamp":1760115290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":32,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247734"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247734","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}